Evidence map›Paper›PMID 40578904›Full record

ArticleBMJ open ophthalmology2025

Development and evaluation of a quality-of-life questionnaire for patients with orbital malignant tumours.

Haihan Yan, Junlian Lang, Shaoxiao Yan, Li Wang, Rui Liu, Nan Wang, Liangyuan Xu, Qihan Guo, Tingting Ren, Runzi Yang and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Haihan YanBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.ORCID 0000-0003-1710-2890
Junlian LangBeijing HuiLongGuan Hospital, Peking University, Beijing, China.
Shaoxiao YanBeijing HuiLongGuan Hospital, Peking University, Beijing, China.
Li WangDepartment of Ophthalmic Nursing, Beijing Tongren hospital, Capital Medical University, Beijing, People's Republic of China.
Rui LiuBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.ORCID 0000-0002-1826-5686
Nan WangBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.
Liangyuan XuBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.
Qihan GuoBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.ORCID 0000-0002-4158-3623
Tingting RenBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.
Runzi YangBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.ORCID 0009-0000-5043-6660
Yufei ZhangBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.
Feng KeBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.
Jianmin MaBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China jmma@sina.com.ORCID 0000-0001-8667-8645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOrbital malignant tumours seriously affect the quality of life of patients; however, there is currently no quality-of-life questionnaire for patients with orbital malignant tumours.

objectiveTo develop and evaluate a quality-of-life questionnaire for patients with orbital malignant tumours.

methodsA pool of items was generated through a literature search, expert meeting and patient interview. Pre-survey and scale evaluation were performed, the quality-of-life questionnaire for patients with orbital malignant tumours (QLQ-OT) was modified, and the scale was evaluated by measuring the quality of life of 46 patients with orbital tumours.

resultsThe effective rate of QLQ-OT was 97.4%, the Cronbach's alpha coefficient was >0.6, and the test-retest reliability Intraclass Correlation Coefficient was >0.7, suggesting good internal consistency and test-retest reliability. The Pearson correlation coefficients were >0.8 between individual domain scores; > 0.6 between items and their own domains in the QLQ-OT; and >0.6 between domains and their corresponding domains in Quality of Life Center Questionnaire, thereby indicating good content, convergent and criterion-related validity. Ten principal components (the initial eigenvalues >1) were abstracted from 38 items of the general by factor analysis, accounting for 81.0% of cumulative variance.

conclusionsQLQ-OT has good compliance, reliability, validity and responsiveness and can be used to measure the quality of life of patients with orbital malignant tumours.

Indexed as

Orbital NeoplasmsQuality of LifeAdolescentAdultAgedFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsSurveys and QuestionnairesYoung AdultOrbit

Identifiers

PMID40578904
PMCPMC12207172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.